» Articles » PMID: 34363586

Incidence of De Quervain's Thyroiditis During the COVID-19 Pandemic in an Area Heavily Affected by Sars-CoV-2 Infection

Overview
Journal Endocrine
Specialty Endocrinology
Date 2021 Aug 7
PMID 34363586
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the possible association between Covid-19 infection and subacute thyroiditis.

Methods: We reviewed the medical and imaging records of patients referred to our Department's outpatient setting dedicated to 'thyroid emergency' (records with a 'bollino verde'-green sticker, classifed as urgent) from April 2020 to October 2020. This outpatient clinic is devoted to patients requiring evaluation for severe hypothyroidism, thyrotoxicosis and neck discomfort or pain. All patients with a newly-diagnosed subacute thyroiditis were selected. The data of all patients receiving a diagnosis of subacute thyroiditis was collected retrospectively, taking into account the same period of time (April-October) and starting from 2016.

Results: During the COVID-19 outbreak in our region (April 2020 to October 2020) 396 patients attended the outpatient emergency clinic. Among them, 10 (2.5%) patients received a diagnosis of subacute thyroiditis. In a single patient, a 44-year-old man, a COVID-19 pulmonary infection had been diagnosed 7 weeks before the diagnosis of subacute thyroiditis. All of the remaining patients were and remain COVID-19 free as confirmed by telephone interview. The percentage of patients who received a diagnosis of subacute thyroiditis in the same period starting from 2016 was very similar (2.9%, 2.9%, 2.6% and 3.0% in 2016, 2017, 2018 and 2019, respectively).

Conclusions: Our data do not show an increase in the incidence of subacute thyroiditis in the Brescia area, a region with the highest prevalence of COVID-19 in Italy during the period of the pandemic outbreak.

Citing Articles

Subacute thyroiditis in pregnancy: a narrative review.

Kaykhaei M, Heidari Z Thyroid Res. 2025; 18(1):4.

PMID: 39956913 PMC: 11831839. DOI: 10.1186/s13044-024-00221-8.


Thyroid dysfunction in COVID-19.

Lui D, Lee C, Woo Y, Hung I, Lam K Nat Rev Endocrinol. 2024; 20(6):336-348.

PMID: 38347167 DOI: 10.1038/s41574-023-00946-w.


HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.

Yasuda S, Suzuki S, Yanagisawa S, Morita H, Haisa A, Satomura A BMC Endocr Disord. 2023; 23(1):54.

PMID: 36879263 PMC: 9988595. DOI: 10.1186/s12902-023-01287-5.


The Influence of SARS-CoV-2 Infection on the Thyroid Gland.

Piekarska A, Goral M, Kozula M, Jawiarczyk-Przybylowska A, Zawadzka K, Bolanowski M Biomedicines. 2023; 11(2).

PMID: 36831150 PMC: 9953074. DOI: 10.3390/biomedicines11020614.


Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.

Viola N, Brancatella A, Sgro D, Santini F, Latrofa F Endocrine. 2022; 79(3):448-454.

PMID: 36394704 PMC: 9670060. DOI: 10.1007/s12020-022-03247-w.


References
1.
Ippolito S, Dentali F, Tanda M . SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020; 43(8):1171-1172. PMC: 7266411. DOI: 10.1007/s40618-020-01312-7. View

2.
Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

3.
Turner A, Tipnis S, Guy J, Rice G, Hooper N . ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol. 2002; 80(4):346-53. DOI: 10.1139/y02-021. View

4.
Conti S, Ferrara P, Mazzaglia G, DOrso M, Ciampichini R, Fornari C . Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy. ERJ Open Res. 2020; 6(3). PMC: 7520169. DOI: 10.1183/23120541.00458-2020. View

5.
Leung W, To K, Chan P, Chan H, Wu A, Lee N . Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003; 125(4):1011-7. PMC: 7126982. DOI: 10.1016/s0016-5085(03)01215-0. View